These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28399250)

  • 41. [Helicobacter pylori and gastroduodenal pathology. Second part: Clinical aspects and therapy].
    Sobhani I; Flourié B; Lavergne A; Colimon R; Mignon M; Modigliani R; Rambaud JC
    Gastroenterol Clin Biol; 1991; 15(5):412-20. PubMed ID: 2070962
    [No Abstract]   [Full Text] [Related]  

  • 42. [Helicobacter pylori infections].
    Nasu M
    Nihon Naika Gakkai Zasshi; 1993 Mar; 82(3):437-40. PubMed ID: 8315343
    [No Abstract]   [Full Text] [Related]  

  • 43. Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial.
    Lee JY; Kim N; Park KS; Kim HJ; Park SM; Baik GH; Shim KN; Oh JH; Choi SC; Kim SE; Kim WH; Park SY; Kim GH; Lee BE; Jo Y; Hong SJ
    BMC Gastroenterol; 2016 Jul; 16(1):79. PubMed ID: 27460100
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Eradication of Helicobacter pylori normalizes elevated mucosal levels of epidermal growth factor and its receptor.
    Coyle WJ; Sedlack RE; Nemec R; Peterson R; Duntemann T; Murphy M; Lawson JM
    Am J Gastroenterol; 1999 Oct; 94(10):2885-9. PubMed ID: 10520838
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Helicobacter pylori infection.
    Suerbaum S; Michetti P
    N Engl J Med; 2002 Oct; 347(15):1175-86. PubMed ID: 12374879
    [No Abstract]   [Full Text] [Related]  

  • 46. Management of Helicobacter pylori-positive peptic ulcer disease.
    Malfertheiner P
    Scand J Gastroenterol Suppl; 1996; 215():69. PubMed ID: 8722386
    [No Abstract]   [Full Text] [Related]  

  • 47. Campylobacter pylori in upper digestive tract diseases in children.
    Celińska-Cedro D; Socha J; Teisseyre M
    Mater Med Pol; 1989; 21(4):259-62. PubMed ID: 2489238
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
    Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O
    Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of a new bismuth-free triple therapy in nude mice and humans.
    Karita M; Tsuda M; Okita K; Sugiyama T; Nakazawa T
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S31-4. PubMed ID: 8574732
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Helicobacter pylori as a class I carcinogen: physiopathology and management strategies.
    Vogiatzi P; Cassone M; Luzzi I; Lucchetti C; Otvos L; Giordano A
    J Cell Biochem; 2007 Oct; 102(2):264-73. PubMed ID: 17486575
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Helicobacter pylori in peptic ulcer disease.
    Del Med J; 1994 Oct; 66(10):557-8. PubMed ID: 7958122
    [No Abstract]   [Full Text] [Related]  

  • 52. Unsuccessful treatment results in survival of less virulent genotypes of Helicobacter pylori in Colombian patients.
    Correa P; van Doorn LJ; Bravo JC; Ruiz B; Bravo LE; Realpe JL
    Am J Gastroenterol; 2000 Feb; 95(2):564-6. PubMed ID: 10685783
    [No Abstract]   [Full Text] [Related]  

  • 53. [A consensus on some problems of Helicobacter pylori (draft)].
    Zhonghua Nei Ke Za Zhi; 1997 Jul; 36(7):438-9. PubMed ID: 10436941
    [No Abstract]   [Full Text] [Related]  

  • 54. Eczema responsive to treatment for Helicobacter pylori.
    Wilson WH
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):290. PubMed ID: 7552934
    [No Abstract]   [Full Text] [Related]  

  • 55. Comparison of antimicrobial activity of zinc chloride and bismuth subsalicylate against clinical isolates of Helicobacter pylori.
    Yakoob J; Abbas Z; Usman MW; Awan S; Naz S; Jafri F; Hamid S; Jafri W
    Microb Drug Resist; 2014 Aug; 20(4):305-9. PubMed ID: 23844851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Reflections on the Nobel prize, the Helicobacter pylori, the peptic ulcer and the scientific paradigms].
    López Vidal Y; Ponce de León S
    Rev Invest Clin; 2006; 58(1):6-8. PubMed ID: 16789594
    [No Abstract]   [Full Text] [Related]  

  • 57. [From a controversial minor finding to the Nobel Prize. The discovery of Helicobacter pylori--an unlikely tale of success].
    Engstrand L; Enroth H
    Lakartidningen; 2005 Dec 5-11; 102(49):3779-80, 3785-6. PubMed ID: 16408701
    [No Abstract]   [Full Text] [Related]  

  • 58. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
    Chey WD; Fisher L; Elta GH; Barnett JL; Nostrant T; DelValle J; Hasler WL; Scheiman JM
    Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pharmacoeconomic evaluation of treatment in patients with Helicobacter pylori-associated diseases].
    Samsonov AA; Grechushnikov VB; Andreev DN; Iurenev GL; Korovina TI; Lezhneva IuA; Maev IV
    Ter Arkh; 2014; 86(8):56-61. PubMed ID: 25306745
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial].
    Rodríguez Hernández H; Sánchez Anguiano LF; Quiñones E
    Rev Gastroenterol Mex; 1998; 63(1):21-7. PubMed ID: 10068745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.